ID

39315

Descripción

1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01303679

Link

https://clinicaltrials.gov/show/NCT01303679

Palabras clave

Versiones (1)
  1. 18/12/19 18/12/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

18 de diciembre de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility First Line Metastatic Breast Cancer NCT01303679

Inglés

Eligibility First Line Metastatic Breast Cancer NCT01303679

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
age > 18 ans.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
metastatic breast cancer or locally advanced
Descripción

Secondary malignant neoplasm of female breast | Locally advanced breast cancer

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0346993
UMLS CUI [2]
C3495949
re+, her2-
Descripción

Estrogen receptor positive | HER2 Negative

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0279754
UMLS CUI [2]
C2348908
patient receiving paclitaxel-bevacizumab first line chemotherapy
Descripción

Chemotherapeutics regimen first line of treatment | Paclitaxel | bevacizumab

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2045825
UMLS CUI [2]
C0144576
UMLS CUI [3]
C0796392
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous treatment by exemestane (both in adjuvant or metastatic treatment).
Descripción

Prior Adjuvant Therapy | exemestane | Prior Therapy metastatic

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1514456
UMLS CUI [2]
C0851344
UMLS CUI [3,1]
C1514463
UMLS CUI [3,2]
C1522484
1st line of chemotherapy different thaan paclitaxel-bevacizumab.
Descripción

Cemotherapeutics regimen first line of treatment | Except Paclitaxel | Except Bevacizumab

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2045825
UMLS CUI [2,1]
C0332300
UMLS CUI [2,2]
C0144576
UMLS CUI [3,1]
C0332300
UMLS CUI [3,2]
C0796392
treatment by paclitaxel-bevacizumab > 18 weeks.
Descripción

Prior Therapy | Paclitaxel | bevacizumab

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1514463
UMLS CUI [2]
C0144576
UMLS CUI [3]
C0796392
her2 positifs et/ou récepteurs aux oestrogènes négatifs.
Descripción

HER2 Positive | Estrogen receptor negative

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348909
UMLS CUI [2]
C0279756
previous thrombosis event within the 6 months before inclusion .
Descripción

Thrombosis Event Previous

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0040053
UMLS CUI [1,2]
C0441471
UMLS CUI [1,3]
C0205156
previous significant surgery within the 28 days before treatment start
Descripción

Prior surgery

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0455610
previuous coagulopathy.
Descripción

Blood Coagulation Disorder Previous

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005779
UMLS CUI [1,2]
C0205156
Volver a la parte superior de la página

Similar models

Eligibility First Line Metastatic Breast Cancer NCT01303679

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age > 18 ans.
boolean
C0001779 (UMLS CUI [1])
Secondary malignant neoplasm of female breast | Locally advanced breast cancer
Item
metastatic breast cancer or locally advanced
boolean
C0346993 (UMLS CUI [1])
C3495949 (UMLS CUI [2])
Estrogen receptor positive | HER2 Negative
Item
re+, her2-
boolean
C0279754 (UMLS CUI [1])
C2348908 (UMLS CUI [2])
Chemotherapeutics regimen first line of treatment | Paclitaxel | bevacizumab
Item
patient receiving paclitaxel-bevacizumab first line chemotherapy
boolean
C2045825 (UMLS CUI [1])
C0144576 (UMLS CUI [2])
C0796392 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Prior Adjuvant Therapy | exemestane | Prior Therapy metastatic
Item
previous treatment by exemestane (both in adjuvant or metastatic treatment).
boolean
C1514456 (UMLS CUI [1])
C0851344 (UMLS CUI [2])
C1514463 (UMLS CUI [3,1])
C1522484 (UMLS CUI [3,2])
Cemotherapeutics regimen first line of treatment | Except Paclitaxel | Except Bevacizumab
Item
1st line of chemotherapy different thaan paclitaxel-bevacizumab.
boolean
C2045825 (UMLS CUI [1])
C0332300 (UMLS CUI [2,1])
C0144576 (UMLS CUI [2,2])
C0332300 (UMLS CUI [3,1])
C0796392 (UMLS CUI [3,2])
Prior Therapy | Paclitaxel | bevacizumab
Item
treatment by paclitaxel-bevacizumab > 18 weeks.
boolean
C1514463 (UMLS CUI [1])
C0144576 (UMLS CUI [2])
C0796392 (UMLS CUI [3])
HER2 Positive | Estrogen receptor negative
Item
her2 positifs et/ou récepteurs aux oestrogènes négatifs.
boolean
C2348909 (UMLS CUI [1])
C0279756 (UMLS CUI [2])
Thrombosis Event Previous
Item
previous thrombosis event within the 6 months before inclusion .
boolean
C0040053 (UMLS CUI [1,1])
C0441471 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
Prior surgery
Item
previous significant surgery within the 28 days before treatment start
boolean
C0455610 (UMLS CUI [1])
Blood Coagulation Disorder Previous
Item
previuous coagulopathy.
boolean
C0005779 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial